Arcutis Biotherapeutics, Inc. financial data

Symbol
ARQT on Nasdaq
Industry
Pharmaceutical Preparations
Location
3027 Townsgate Road, Suite 300, Westlake Village, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Arcutis, Inc. (to 9/9/2019)
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 472 % -40.6%
Quick Ratio 15.8 % -44.3%
Debt-to-equity 136 % -50.7%
Return On Equity -77.2 % +73.8%
Return On Assets -32.8 % +58.3%
Operating Margin -65.3 % +83.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119M shares +22.5%
Common Stock, Shares, Outstanding 118M shares +21.8%
Entity Public Float 984M USD +102%
Common Stock, Value, Issued 12K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 121M shares +74.5%
Weighted Average Number of Shares Outstanding, Diluted 121M shares +74.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 197M USD +230%
Research and Development Expense 76.4M USD -30.9%
Costs and Expenses 325M USD +8.06%
Operating Income (Loss) -128M USD +46.7%
Nonoperating Income (Expense) -14.6M USD -354%
Income Tax Expense (Benefit) 647K USD -79.2%
Net Income (Loss) Attributable to Parent -140M USD +46.6%
Earnings Per Share, Basic -1.16 USD/shares +69.3%
Earnings Per Share, Diluted -1.16 USD/shares +69.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.3M USD -19.3%
Accounts Receivable, after Allowance for Credit Loss, Current 73.1M USD +183%
Inventory, Net 14.5M USD +10.6%
Assets, Current 336M USD +1.63%
Property, Plant and Equipment, Net 1.04M USD -32.4%
Operating Lease, Right-of-Use Asset 1.95M USD -17.3%
Intangible Assets, Net (Excluding Goodwill) 9.48M USD +47.2%
Other Assets, Noncurrent 596K USD 0%
Assets 349M USD +2.2%
Accounts Payable, Current 14.2M USD +18.6%
Employee-related Liabilities, Current 20.7M USD +39.5%
Accrued Liabilities, Current 66M USD +94.4%
Liabilities, Current 81M USD +73.6%
Operating Lease, Liability, Noncurrent 2.56M USD -24.2%
Other Liabilities, Noncurrent 570K USD -32.9%
Liabilities 191M USD -24.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7K USD -275%
Retained Earnings (Accumulated Deficit) -1.12B USD -14.3%
Stockholders' Equity Attributable to Parent 158M USD +77.7%
Liabilities and Equity 349M USD +2.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +60.7%
Net Cash Provided by (Used in) Financing Activities 162M USD +61.8%
Net Cash Provided by (Used in) Investing Activities -28.7M USD -127%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 118M shares +21.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 101M USD +269%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 72M USD -19.4%
Deferred Tax Assets, Valuation Allowance 256M USD +18.6%
Deferred Tax Assets, Gross 257M USD +18.5%
Operating Lease, Liability 3.38M USD -17.9%
Depreciation 766K USD +18.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -140M USD +46.4%
Lessee, Operating Lease, Liability, to be Paid 3.82M USD -20.7%
Property, Plant and Equipment, Gross 3.61M USD +4.1%
Operating Lease, Liability, Current 820K USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.05M USD +2.93%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.02M USD +3.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 436K USD -37.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD +3.13%
Deferred Tax Assets, Operating Loss Carryforwards 172M USD +12.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 42.3M USD +2.17%
Lessee, Operating Lease, Liability, to be Paid, Year Four 653K USD -39.9%
Operating Lease, Payments 241K USD +36.9%
Additional Paid in Capital 1.28B USD +19.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 750K USD 0%
Share-based Payment Arrangement, Expense 41.7M USD +7.52%
Interest Expense 30.2M USD +44.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%